OMER News and Press, Omeros Corporation From 11/09/21

– Conference Call Today at 4:30 p.m. ET – Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indicat...

Omeros (OMER -0.6%) said long term follow up data from a phase 2 trial of its medicine narsoplimab to treat patients with IgA nephropathy, a type of kidney disorder, showed improvement and stabilization in renal function. Previous data from the trial showed that narsoplimab led to m...

-- Data Show Improvement and Stabilization in Renal Function -- Unprecedented median proteinuria reduction of 64.4 percent seen in the narsoplimab Phase 2 clinical trial predicts a 41.6-year delay in need for dialysis compared to standard of care Narsoplimab is the f...

-- First Report of Narsoplimab’s Effects on Complement Activation Markers in Renal Disease Presented at the Annual Meeting of the American Society of Nephrology -- Omeros Corporation (Nasdaq: OMER) today announced that the first report describing the effects of lectin...

Omeros Corporation (NASDAQ: OMER) today announced that the company will issue its third quarter financial results for the period ended September 30, 2021, on Tuesday, November 9, 2021, after the market closes. Omeros management will host a conference call and webcast that day at 4:30 p....

Look out below for these tumbling biotech stocks. Shares of Atea Pharmaceuticals (NASDAQ: AVIR) , Omeros (NASDAQ: OMER) , and Novavax (NASDAQ: NVAX) were big winners for investors this year right up until they weren't. When stocks fall, they tend to fall hard. Fo...

Gainers: AlloVir (NASDAQ:ALVR) +14%, InflaRx (NASDAQ:IFRX) +14%, Harmony Biosciences (NASDAQ:HRMY) +13%, Omeros (NASDAQ:OMER) +11%, Prelude Therapeutics (NASDAQ:PRLD) +11%. Losers: Galera Therapeutics (NASDAQ:GRTX) -68%, Atea Pharmaceutic...

Gainers: ION Geophysical (NYSE:IO) +42%. Valneva (NASDAQ:VALN) +33%. Progenity (NASDAQ:PROG) +31%. MeiraGTx (NASDAQ:MGTX) +30%. BTCS (NASDAQ:BTCS) +22%. Peabody Energy (NYSE:BTU) +20%. Evolving Systems (NASDAQ:EVOL) +18%. InMed (NASDAQ:INM) +16%. TORM (NASDAQ:TRMD) +17%. Aerovate (NASDAQ:AVTE...

Omeros (NASDAQ: OMER) stock is falling hard again for the second time this month. A complete response letter from the FDA for narsoplimab is the culprit today. Disappointed investors have pushed the stock 23.7% lower as of 11:43 a.m. EDT on Monday. Omeros is a commercial-sta...

Gainers: Valneva SE VALN +33%, MeiraGTx (NASDAQ:MGTX) +22%, Adamis Pharmaceuticals ADMP +20%, Aerovate Therapeutics AVTE +18%, Progenity (NASDAQ:PROG) +16%. Losers: Revance Therapeutics RVNC -42%, Omeros OMER -25%, MannKind MNKD...